The U.S. Food and Drug Administration will remove the "black box" warning labels on many hormone therapy drugs used for menopause and perimenopause symptoms -- a major turnaround that's likely to ...

The US Food and Drug Administration found no increased risk of suicidal behavior or ideation linked to popular weight-loss drugs, the regulator said in a letter Tuesday, and asked companies to remove ...

A "black box" warning on a health product sounds pretty scary—maybe even more so when it's suddenly being taken off the packaging. Subscribe to our newsletter for the latest sci-tech news updates.

WASHINGTON (AP) — Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the ...

Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the Food and Drug ...

Studies in the early 2000s claimed there were major risks associated with HRT. The Food and Drug Administration said Monday it will remove the "black box" warning from hormone replacement therapy (HRT ...

SILVER SPRING, Md. — The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight loss drugs, including Novo ...

The Food and Drug Administration on Tuesday told Eli Lilly and Novo Nordisk to remove warnings about the risk of suicidal thoughts and behavior from the labels of their blockbuster GLP-1 weight-loss ...

WASHINGTON — Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the Food ...

(THE CONVERSATION) A “black box” warning on a health product sounds pretty scary – maybe even more so when it’s suddenly being taken off the packaging. Americans were reminded of this type of public ...